{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T19:48:16Z","timestamp":1765828096815,"version":"3.37.3"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,11,11]],"date-time":"2021-11-11T00:00:00Z","timestamp":1636588800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2021,11,11]],"date-time":"2021-11-11T00:00:00Z","timestamp":1636588800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"Charlies Foundation for Research","award":["MRGP 21\/22"],"award-info":[{"award-number":["MRGP 21\/22"]}]},{"DOI":"10.13039\/100008158","name":"Arthritis Foundation of Australia","doi-asserted-by":"publisher","award":["RA\/1\/108\/32"],"award-info":[{"award-number":["RA\/1\/108\/32"]}],"id":[{"id":"10.13039\/100008158","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008158","name":"Arthritis foundation of Western Australia","doi-asserted-by":"crossref","award":["unrestricted grant"],"award-info":[{"award-number":["unrestricted grant"]}],"id":[{"id":"10.13039\/100008158","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Ther"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1007\/s40744-021-00393-x","type":"journal-article","created":{"date-parts":[[2021,11,11]],"date-time":"2021-11-11T07:04:53Z","timestamp":1636614293000},"page":"127-137","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["The Association Between TNF Inhibitor Therapy Availability and Hospital Admission Rates for Patients with Ankylosing Spondylitis. A Longitudinal Population-Based Study"],"prefix":"10.1007","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2833-7997","authenticated-orcid":false,"given":"Johannes","family":"Nossent","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles","family":"Inderjeeth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helen","family":"Keen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Preen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erin","family":"Kelty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,11,11]]},"reference":[{"issue":"9","key":"393_CR1","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1007\/s11926-013-0351-1","volume":"15","author":"G Bakland","year":"2013","unstructured":"Bakland G, Nossent HC. Epidemiology of spondyloarthritis: a review. Curr Rheumatol Rep. 2013;15(9):351.","journal-title":"Curr Rheumatol Rep"},{"issue":"2","key":"393_CR2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0211835","volume":"14","author":"LY Hu","year":"2019","unstructured":"Hu LY, Lu T, Chen PM, Shen CC, Hung YM, Hsu CL. Should clinicians pay more attention to the potential underdiagnosis of osteoporosis in patients with ankylosing spondylitis? A national population-based study in Taiwan. PLoS ONE. 2019;14(2): e0211835.","journal-title":"PLoS ONE"},{"issue":"5","key":"393_CR3","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1080\/14712598.2020.1704727","volume":"20","author":"F Atzeni","year":"2020","unstructured":"Atzeni F, Nucera V, Galloway J, Zoltan S, Nurmohamed M. Cardiovascular risk in ankylosing spondylitis and the effect of anti-TNF drugs: a narrative review. Expert Opin Biol Ther. 2020;20(5):517\u201324.","journal-title":"Expert Opin Biol Ther"},{"issue":"11","key":"393_CR4","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.3899\/jrheum.190675","volume":"47","author":"M Ognjenovic","year":"2020","unstructured":"Ognjenovic M, Raymond WD, Inderjeeth CA, Keen HI, Preen DB, Nossent JC. The risk and consequences of vertebral fracture in patients with ankylosing spondylitis: a population-based data linkage study. J Rheumatol. 2020;47(11):1629\u201336.","journal-title":"J Rheumatol"},{"issue":"11","key":"393_CR5","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1136\/ard.2011.151191","volume":"70","author":"G Bakland","year":"2011","unstructured":"Bakland G, Gran JT, Nossent JC. Increased mortality in ankylosing spondylitis is related to disease activity. Ann Rheum Dis. 2011;70(11):1921\u20135.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"393_CR6","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1097\/RHU.0000000000000750","volume":"25","author":"P Chiowchanwisawakit","year":"2019","unstructured":"Chiowchanwisawakit P, Thaweeratthakul P, Wattanamongkolsil L, Srinonprasert V, Koolvisoot A, Muangchan C, et al. Relationship between health-related quality of life and patient acceptable symptom state with disease activity and functional status in patients with ankylosing spondylitis in Thailand. J Clin Rheumatol. 2019;25(1):16\u201323.","journal-title":"J Clin Rheumatol"},{"issue":"3","key":"393_CR7","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1111\/1756-185X.13758","volume":"23","author":"SH Lee","year":"2020","unstructured":"Lee SH, Park YW, Choe JY, Shin K, Kwon SR, Cha JH, et al. Gastrointestinal risk factors and patient-reported outcomes of ankylosing spondylitis in Korea. Int J Rheum Dis. 2020;23(3):342\u20139.","journal-title":"Int J Rheum Dis"},{"key":"393_CR8","volume":"1","author":"H Radner","year":"2012","unstructured":"Radner H, Ramiro S, Buchbinder R, Landewe RB, van der Heijde D, Aletaha D. Pain management for inflammatory arthritis (rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis and other spondylarthritis) and gastrointestinal or liver comorbidity. Cochrane Database Syst Rev. 2012;1: CD008951.","journal-title":"Cochrane Database Syst Rev"},{"key":"393_CR9","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005468.pub2","author":"LJ Maxwell","year":"2015","unstructured":"Maxwell LJ, Zochling J, Boonen A, Singh JA, Veras MM, Tanjong Ghogomu E, et al. TNF-alpha inhibitors for ankylosing spondylitis. Cochrane Database Syst Rev. 2015. https:\/\/doi.org\/10.1002\/14651858.CD005468.pub2.","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"393_CR10","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.3899\/jrheum.091042","volume":"37","author":"RD Inman","year":"2010","unstructured":"Inman RD, Maksymowych WP, Group CS. A double-blind, placebo-controlled trial of low dose infliximab in ankylosing spondylitis. J Rheumatol. 2010;37(6):1203\u201310.","journal-title":"J Rheumatol"},{"issue":"4","key":"393_CR11","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.rdc.2019.07.003","volume":"45","author":"E Nikiphorou","year":"2019","unstructured":"Nikiphorou E, Baraliakos X. Treat to Target in Axial Spondyloarthritis. Rheum Dis Clin N Am. 2019;45(4):519\u201335.","journal-title":"Rheum Dis Clin N Am"},{"issue":"6","key":"393_CR12","doi-asserted-by":"publisher","first-page":"409","DOI":"10.7326\/M14-2470","volume":"163","author":"NN Haroon","year":"2015","unstructured":"Haroon NN, Paterson JM, Li P, Inman RD, Haroon N. Patients with ankylosing spondylitis have increased cardiovascular and cerebrovascular mortality: a population-based study. Ann Intern Med. 2015;163(6):409\u201316.","journal-title":"Ann Intern Med"},{"issue":"2","key":"393_CR13","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1080\/14712598.2020.1694900","volume":"20","author":"J Tuzil","year":"2020","unstructured":"Tuzil J, Mlcoch T, Jircikova J, Zavada J, Nekvindova L, Svoboda M, et al. Short-term response in new users of anti-TNF predicts long-term productivity and non-disability: analysis of Czech ATTRA ankylosing spondylitis biologic registry. Expert Opin Biol Ther. 2020;20(2):183\u201392.","journal-title":"Expert Opin Biol Ther"},{"issue":"42","key":"393_CR14","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2019.34.e278","volume":"34","author":"S Lee","year":"2019","unstructured":"Lee S, Park YJ, Lee JY. The effect of tumor necrosis factor-alpha inhibitors on uveitis in patients with ankylosing spondylitis. J Korean Med Sci. 2019;34(42): e278.","journal-title":"J Korean Med Sci"},{"issue":"6","key":"393_CR15","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1615\/CritRevImmunol.2020033205","volume":"39","author":"AB Kunnumakkara","year":"2019","unstructured":"Kunnumakkara AB, Thakur KK, Rana V, Bora B, Banik K, Khatoon E, et al. Upside and downside of tumor necrosis factor blockers for treatment of immune\/inflammatory diseases. Crit Rev Immunol. 2019;39(6):439\u201379.","journal-title":"Crit Rev Immunol"},{"issue":"1","key":"393_CR16","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s41927-020-0118-z","volume":"4","author":"A Deodhar","year":"2020","unstructured":"Deodhar A, Strand V, Conaghan PG, Sullivan E, Blackburn S, Tian H, et al. Unmet needs in ankylosing spondylitis patients receiving tumour necrosis factor inhibitor therapy; results from a large multinational real-world study. BMC Rheumatol. 2020;4(1):19.","journal-title":"BMC Rheumatol"},{"issue":"1","key":"393_CR17","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2019-001145","volume":"6","author":"J Marona","year":"2020","unstructured":"Marona J, Sepriano A, Rodrigues-Manica S, Pimentel-Santos F, Mour\u00e3o AF, Gouveia N, et al. Eligibility criteria for biologic disease-modifying antirheumatic drugs in axial spondyloarthritis: going beyond BASDAI. RMD Open. 2020;6(1): e001145.","journal-title":"RMD Open"},{"issue":"12","key":"393_CR18","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1136\/ard.2005.042630","volume":"65","author":"T Pham","year":"2006","unstructured":"Pham T, Landewe R, van der Linden S, Dougados M, Sieper J, Braun J, et al. An international study on starting tumour necrosis factor-blocking agents in ankylosing spondylitis. Ann Rheum Dis. 2006;65(12):1620\u20135.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"393_CR19","doi-asserted-by":"publisher","DOI":"10.1002\/prp2.708","volume":"9","author":"AB Mendelsohn","year":"2021","unstructured":"Mendelsohn AB, Nam YH, Marshall J, McDermott CL, Kochar B, Kappelman MD, et al. Utilization patterns and characteristics of users of biologic anti-inflammatory agents in a large, US commercially insured population. Pharmacol Res Perspect. 2021;9(1): e00708.","journal-title":"Pharmacol Res Perspect"},{"key":"393_CR20","doi-asserted-by":"publisher","first-page":"212556","DOI":"10.7573\/dic.212556","volume":"7","author":"D Opris-Belinski","year":"2018","unstructured":"Opris-Belinski D, Erdes SF, Grazio S, Senolt L, Hojnik M, Nagy O, et al. Impact of adalimumab on clinical outcomes, healthcare resource utilization, and sick leave in patients with ankylosing spondylitis: an observational study from five Central and Eastern European countries. Drugs Context. 2018;7:212556.","journal-title":"Drugs Context"},{"key":"393_CR21","unstructured":"Excellence NIFHAC. TNF-alpha inhibitors for ankylosing spondylitis and non-radiographic axial spondyloarthritis. Technology appraisal guidance [Internet]. 2016, p. 70. www.nice.org.uk\/guidance\/ta383. Accessed 2 Feb 2021."},{"issue":"5","key":"393_CR22","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1080\/14740338.2018.1448785","volume":"17","author":"S D'Angelo","year":"2018","unstructured":"D\u2019Angelo S, Carriero A, Gilio M, Ursini F, Leccese P, Palazzi C. Safety of treatment options for spondyloarthritis: a narrative review. Expert Opin Drug Saf. 2018;17(5):475\u201386.","journal-title":"Expert Opin Drug Saf"},{"key":"393_CR23","doi-asserted-by":"publisher","DOI":"10.1002\/acr.24616","author":"N Ben-Shabat","year":"2021","unstructured":"Ben-Shabat N, Shabat A, Watad A, Kridin K, Bragazzi NL, McGonagle D, et al. Mortality in ankylosing spondylitis according to treatment: a nationwide retrospective cohort study of 5900 patients from Israel. Arthritis Care Res (Hoboken). 2021. https:\/\/doi.org\/10.1002\/acr.24616.","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"2","key":"393_CR24","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1080\/14397595.2020.1775927","volume":"31","author":"T Tomita","year":"2021","unstructured":"Tomita T, Sato M, Esterberg E, Parikh RC, Hagimori K, Nakajo K. Treatment patterns and health care resource utilization among Japanese patients with ankylosing spondylitis: a hospital claims database analysis. Mod Rheumatol. 2021;31(2):431\u201341.","journal-title":"Mod Rheumatol"},{"issue":"1","key":"393_CR25","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2019-001140","volume":"6","author":"M Holland-Fischer","year":"2020","unstructured":"Holland-Fischer M, Thomsen RW, Tarp U, Norgaard M. Ankylosing spondylitis and mortality following hospitalised pneumonia: a population-based cohort study. RMD Open. 2020;6(1): e001140.","journal-title":"RMD Open"},{"issue":"4","key":"393_CR26","doi-asserted-by":"publisher","first-page":"3491","DOI":"10.3892\/etm.2017.5003","volume":"14","author":"Z Xu","year":"2017","unstructured":"Xu Z, Xu P, Fan W, Yang G, Wang J, Cheng Q, et al. Risk of infection in patients with spondyloarthritis and ankylosing spondylitis receiving antitumor necrosis factor therapy: a meta-analysis of randomized controlled trials. Exp Ther Med. 2017;14(4):3491\u2013500.","journal-title":"Exp Ther Med"},{"key":"393_CR27","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.jaut.2017.02.003","volume":"79","author":"Y Komaki","year":"2017","unstructured":"Komaki Y, Yamada A, Komaki F, Kudaravalli P, Micic D, Ido A, et al. Efficacy, safety and pharmacokinetics of biosimilars of anti-tumor necrosis factor-alpha agents in rheumatic diseases; a systematic review and meta-analysis. J Autoimmun. 2017;79:4\u201316.","journal-title":"J Autoimmun"},{"issue":"2","key":"393_CR28","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1097\/BOR.0000000000000475","volume":"30","author":"R Wang","year":"2018","unstructured":"Wang R, Ward MM. Epidemiology of axial spondyloarthritis: an update. Curr Opin Rheumatol. 2018;30(2):137\u201343.","journal-title":"Curr Opin Rheumatol"},{"issue":"3","key":"393_CR29","doi-asserted-by":"publisher","first-page":"479","DOI":"10.3899\/jrheum.100686","volume":"38","author":"G Bakland","year":"2011","unstructured":"Bakland G, Gran JT, Becker-Merok A, Nordvag BY, Nossent JC. Work disability in patients with ankylosing spondylitis in Norway. J Rheumatol. 2011;38(3):479\u201384.","journal-title":"J Rheumatol"},{"issue":"9","key":"393_CR30","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s11926-020-00932-5","volume":"22","author":"E Nikiphorou","year":"2020","unstructured":"Nikiphorou E, Ramiro S. Work disability in axial spondyloarthritis. Curr Rheumatol Rep. 2020;22(9):55.","journal-title":"Curr Rheumatol Rep"},{"issue":"4","key":"393_CR31","first-page":"254","volume":"44","author":"J Rodrigues","year":"2019","unstructured":"Rodrigues J, Rodrigues AM, Dias SS, Sousa RD, Branco JC, Canhao H. Psoriatic arthritis and ankylosing spondylitis impact on health-related quality of life and working life: a comparative population-based study. Acta Reumatol Port. 2019;44(4):254\u201365.","journal-title":"Acta Reumatol Port"},{"issue":"11","key":"393_CR32","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1136\/annrheumdis-2018-213590","volume":"77","author":"J Shim","year":"2018","unstructured":"Shim J, Jones GT, Pathan EMI, Macfarlane GJ. Impact of biological therapy on work outcomes in patients with axial spondyloarthritis: results from the British Society for Rheumatology Biologics Register (BSRBR-AS) and meta-analysis. Ann Rheum Dis. 2018;77(11):1578\u201384.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"393_CR33","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s00393-019-0678-8","volume":"79","author":"I Redeker","year":"2020","unstructured":"Redeker I, Callhoff J, Hoffmann F, Saam J, Haibel H, Sieper J, et al. Krankheitskosten bei axialer Spondyloarthritis f\u00fcr Patienten mit und ohne Tumor-Nekrose-Faktor-Inhibitor-Behandlung: Ergebnisse einer Routinedatenanalyse. Z Rheumatol. 2020;79(1):85\u201394.","journal-title":"Z Rheumatol"}],"container-title":["Rheumatology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40744-021-00393-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40744-021-00393-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40744-021-00393-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,3]],"date-time":"2022-02-03T12:46:52Z","timestamp":1643892412000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40744-021-00393-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,11]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["393"],"URL":"https:\/\/doi.org\/10.1007\/s40744-021-00393-x","relation":{},"ISSN":["2198-6576","2198-6584"],"issn-type":[{"type":"print","value":"2198-6576"},{"type":"electronic","value":"2198-6584"}],"subject":[],"published":{"date-parts":[[2021,11,11]]},"assertion":[{"value":"3 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 October 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}